Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1050 of 1467 entries
View as:

Efficacy and Safety Study of Ataciguat Versus Placebo in Patients With Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00799656 Org: User:
Start: 11/30/08 End: 09/30/09 Due: 09/30/10

Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02664103 Org: User:
Start: 01/23/16 End: 11/06/17 Due: 11/06/18

Glulisine Pre- and Postmeal

Phase: N/A Priority: Normal
NCT ID: NCT00290043 Org: User:
Start: 12/31/01 End: 03/31/02 Due: 03/31/03

An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression

Phase: N/A Priority: Normal
NCT ID: NCT00319709 Org: User:
Start: 04/30/06 End: 08/31/07 Due: 08/31/08

Risedronate in Osteopenic Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00345644 Org: User:
Start: 03/31/06 End: 06/30/09 Due: 06/30/10

ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH

Phase: N/A Priority: Normal
NCT ID: NCT00290030 Org: User:
Start: 05/31/01 End: 10/31/04 Due: 10/31/05

ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week

Phase: N/A Priority: Normal
NCT ID: NCT00544180 Org: User:
Start: 05/31/05 End: - Due: -

Safety, Tolerability and Pharmacokinetics of SAR113945 Following Intra-articular Administration in Patients With Knee Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT01113333 Org: User:
Start: 04/30/10 End: 02/28/11 Due: 02/28/12

Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00358176 Org: User:
Start: 07/31/04 End: 03/31/07 Due: 03/31/08

Insulin Glulisine in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00360698 Org: User:
Start: 07/31/06 End: 08/31/08 Due: 08/31/09

Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)

Phase: N/A Priority: Normal
NCT ID: NCT00390728 Org: User:
Start: 04/30/02 End: 08/31/03 Due: 08/31/04

Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China

Phase: N/A Priority: Normal
NCT ID: NCT05680298 Org: User:
Start: 02/22/23 End: 03/15/24 Due: 03/15/25

Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00378573 Org: User:
Start: 01/31/07 End: 09/30/08 Due: 09/30/09

COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00814268 Org: User:
Start: 12/31/08 End: 05/31/12 Due: 05/31/13

Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid) - Safety

Phase: N/A Priority: Normal
NCT ID: NCT00785148 Org: User:
Start: 08/31/08 End: - Due: -

Benign Prostatic Hyperplasia in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT00941343 Org: User:
Start: 09/30/06 End: 09/30/08 Due: 09/30/09

ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children

Phase: N/A Priority: Normal
NCT ID: NCT00457353 Org: User:
Start: 03/31/07 End: - Due: -

A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT06704932 Org: User:
Start: 11/20/24 End: 12/25/25 Due: 12/25/26

Real World Study on the Use of Cemiplimab in Adult Patients in UK

Phase: N/A Priority: Normal
NCT ID: NCT05493826 Org: User:
Start: 07/18/22 End: 11/01/22 Due: 11/01/23

A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)

Phase: N/A Priority: Normal
NCT ID: NCT04913220 Org: User:
Start: 07/15/21 End: 02/18/25 Due: 02/18/26

Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02513186 Org: User:
Start: 09/30/15 End: 01/22/24 Due: 01/22/25

Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT05042440 Org: User:
Start: 08/11/21 End: 11/24/21 Due: 11/24/22

A Randomized Controlled Trial to Compare the Glycemic Control, With or Without the Connected Solution, of Adult Type 2 Diabetic Participants on Basal Insulin in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT05684341 Org: User:
Start: 02/17/23 End: 06/18/24 Due: 06/18/25

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility

Phase: N/A Priority: Normal
NCT ID: NCT00714597 Org: User:
Start: 07/31/08 End: 03/31/09 Due: 03/31/10

A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03903016 Org: User:
Start: 03/26/19 End: 08/19/19 Due: 08/19/20